EUVIMEDEUVIMED entdecken
Crossref

The Effect of Zonisamide on Rat Bone Mass, Structure, and Metabolism

Iva Karesova, Julius Simko, Sona Fekete, Eva Zimcikova, Jana Malakova, Helena Zivna, Ladislava Pavlikova, Vladimir Palicka

Pharmacology · 2023

DOI: 10.1159/000529970 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmacology, 2023. Verfasst von Iva Karesova und 7 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Clinical Biochemistry and Diagnostics, Charles University in Prague, Faculty of Medicine and University Hospital, Hradec Kralove, Czechi…. Hauptthemen laut MEDLINE: Bone Density, Bone and Bones. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 29 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Our study aimed to investigate the effect of zonisamide (ZNS) on bone metabolism in the rat model.

Methods

Eight-week-old rats were divided into four groups. The sham-operated control group (SHAM) and the control group after orchidectomy (ORX) received the standard laboratory diet (SLD). The experimental group after orchidectomy (ORX+ZNS) and the sham-operated control group (SHAM+ZNS) received SLD enriched with ZNS for 12 weeks. Bone marker concentrations in serum of receptor activator of nuclear factor kappa B ligand, PINP, and osteoprotegerin, and the levels of sclerostin and bone alkaline phosphatase in bone homogenate, were measured using an enzyme-linked immunosorbent assay. Bone mineral density (BMD) was measured by dual-energy X-ray absorptiometry. The femurs were used for biomechanical testing.

Results

We found a statistically significant reduction in BMD and biomechanical strength 12 weeks after orchidectomy of the rats (ORX). After ZNS administration to orchidectomized rats (ORX+ZNS) and the sham-operated control rats (SHAM+ZNS), there were no statistically significant changes in BMD, bone turnover markers, or biomechanical properties as compared with the ORX group and SHAM group.

Conclusions

The results suggest that administration of ZNS to rats exerts no negative effect on BMD, bone metabolism markers, or biomechanical properties.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bone DensityBone and BonesRatsAnimalsMaleZonisamideRats, WistarOrchiectomySulfidesZinc Compounds

Stichwörter der Autor:innen

Antiepileptic drugsBiomechanical propertiesBone markersBone mineral densityZonisamide

Substanzen

Zonisamidezinc sulfideSulfidesZinc Compounds

Autor:innen und Institutionen

  • Institute of Clinical Biochemistry and Diagnostics, Charles University in Prague, Faculty of Medicine and University Hospital, Hradec Kralove, Czechia.
  • Department of Neurology, Charles University in Prague, Faculty of Medicine and University Hospital, Hradec Kralove, Czechia.
  • Department of Social and Clinical Pharmacy, Faculty of Pharmacy in Hradec Kralove, Charles University in Prague, Hradec Kralove, Czechia.
  • Radioisotope Laboratories and Vivarium, Faculty of Medicine, Hradec Kralove, Czechia.

Zitieren

APA

Karesova, I., Simko, J., Fekete, S., Zimcikova, E., Malakova, J., Zivna, H., Pavlikova, L., & Palicka, V. (2023). The Effect of Zonisamide on Rat Bone Mass, Structure, and Metabolism. Pharmacology. https://doi.org/10.1159/000529970

Vancouver

Karesova I, Simko J, Fekete S, Zimcikova E, Malakova J, Zivna H, et al. The Effect of Zonisamide on Rat Bone Mass, Structure, and Metabolism. Pharmacology. 2023. doi:10.1159/000529970

BibTeX
@article{Karesova2023,
  author = {Karesova, Iva and Simko, Julius and Fekete, Sona and Zimcikova, Eva and Malakova, Jana and Zivna, Helena and Pavlikova, Ladislava and Palicka, Vladimir},
  title = {The Effect of Zonisamide on Rat Bone Mass, Structure, and Metabolism},
  journal = {Pharmacology},
  year = {2023},
  doi = {10.1159/000529970}
}
Kostenlos starten →